Educational material on asthma

Interactive e-learning content

Guidelines

European Respiratory Society Guidelines for the Diagnosis of Asthma in Adults R. Louis, I. Satia, I. Ojanguren et al. European Respiratory Journal 2022; DOI: 10.1183/13993003.01585-2021
European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5–16 years E. Gaillard, C. Kuehni, S. Turner et al. Eur Respir J 2021, 58: 2004173
ERS/EAACI statement on adherence to international adult asthma guidelines A. Mathioudakis, O. Tsilochristou, I. Adcock et al. Eur Respir Rev 2021; 30: 210132
Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline F. Holguin, J. Cardet, K. Chung et al. Eur Respir J 2020, 55: 1900588
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions A. Bourdin, L. Bjermer, C. Brightling et al. Eur Respir J 2019, 54: 1900900
Monitoring asthma in children Pijnenburg, M.W., Baraldi, E., Brand, P.L.P., et al. Eur Respir J 2015; 45: 906–925
Specific inhalation challenge in the diagnosis of occupational asthma Vandenplas, O., Suojalehto. H., Aasen, T.B., et al. Eur Respir J 2014; 43: 1573–1587
International ERS/ATS Guidelines on Definition, Evaluation and Treatment of Severe Asthma Chung, K.F., Wenzel, S.E., Brozek, J.L., et al. Eur Respir J 2014 43:343-373; published ahead of print 2013
Guidelines for the management of work-related asthma X. Baur, T. Sigsgaard, T.B. Aasen, et al. Eur Respir J 2012; 39: 529-545
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations H. K. Reddel, D. R. Taylor, E. D. Bateman, et al. Am J Respir Crit Care Med. 2009; 180: 59-99

CME tests

Medication adherence and the risk of severe asthma exacerbations: a systematic review Engelkes Marjolein, Janssens Hettie M., de Jongste Johan C., Sturkenboom Miriam C.J.M., Verhamme Katia M.C. Eur Respir J 2015; 45: 396-407
Exercise-induced anaphylaxis: an update S.R. Del Giacco Breathe 2012; 8: 299-306
Childhood respiratory cohort studies: do they generate useful outcomes? S. Turner Breathe 2012; 8: 194-204

Webcasts

Introduction A. Sajnic (Zagreb, Croatia), J. Padilha (Porto, Portugal)
Introduction M. Mukherjee (Hamilton (ON), Canada), A. Bossios (Stockholm, Sweden)
Introduction
Introduction L. Uller (Lund, Sweden), F. Salgado Castro (Santiago De Compostela, Spain)
Introduction T. Troosters (Leuven, Belgium), A. Holland (Fitzroy North (VIC), Australia)
Introduction S. Saglani (London, United Kingdom), C. Lex (Goettingen, Germany)
Introduction R. Costello (Dublin 9, Ireland), C. Brightling (Leicester (Leicestershire), United Kingdom)
Interactive cases by participants S. Loukides (Athens, Greece), M. Mukherjee (Hamilton (ON), Canada), A. Yorgancioglu (Konak, Turkey), A. Zacharasiewicz (Wien, Austria), K. Kainz (Wien, Austria)
Pharmacological treatment and current controversies G. Brusselle (Ghent, Belgium)
Making sense of phenotypes and endotypes in asthma R. Louis (Liège, Belgium)
Assessing and monitoring asthma F. Schleich (Liège, Belgium)
Latest updates in the guidelines of asthma: diagnosis and management A. Yorgancioglu (Konak, Turkey)
Wrap-up by discussant and discussion I. Opitz (Zurich, Switzerland)
Endosonography with or without confirmatory mediastinoscopy for resectable lung cancerA randomized clinical trial J. Annema (Amsterdam, Netherlands), J. Bousema (Veldhoven, Netherlands), M. Dijkgraaf (Amsterdam, Netherlands), E. Van Der Heijden (Nijmegen, Netherlands), A. Verhagen (Nijmegen, Netherlands), F. Van Den Broek (Veldhoven, Netherlands)
A randomized controlled trial evaluating the benefit of cone beam CT guidance to electromagnetic navigation bronchoscopy for the diagnosis of pulmonary nodule B. Bondue (Bruxelles, Belgium), O. Taton (Bruxelles, Belgium), F. Tannouri (Bruxelles, Belgium), M. Remmelink (Bruxelles, Belgium), D. Leduc (Bruxelles, Belgium)
Wrap-up by discussant and discussion I. Opitz (Zurich, Switzerland)
Sustained health-related quality of life in patients with severe heterogenous emphysema treated with spiration valve system at 24-month follow-up (EMPROVE) G. Criner (Philadelphia, United States), A. Delage (Sherbrooke, Canada), K. Voelker (Sarasota, Florida, United States), S. Martel (Quebec, Canada), E. The Emprove Trial Investigator Group (Philadelphia, United States)
Comparative Effect of Lung volume reduction surgery for Emphysema and Bronchoscopic lung volume reduction with valve placement: the CELEB trial. S. Buttery (London, United Kingdom), A. Lewis (London, United Kingdom), L. Latimer (Leicester, United Kingdom), S. Kemp (London, United Kingdom), P. Shah (London, United Kingdom), D. Waller (London, United Kingdom), K. Lau (London, United Kingdom), S. Jordan (London, United Kingdom), N. Greening (Leicester, United Kingdom), S. Rathinam (Leicester, United Kingdom), W. Banya (London, United Kingdom), J. Moxham (London, United Kingdom), A. Kirk (West Dumbartonshire, Scotland, United Kingdom), R. Bilancia (West Dumbartonshire, Scotland, United Kingdom), S. Tenconi (Sheffield, United Kingdom), K. Housley (Sheffield, United Kingdom), R. Lawson (Sheffield, United Kingdom), M. Steiner (Leicester, United Kingdom), N. Hopkinson (London, United Kingdom)
Wrap-up by discussant and discussion G. Brusselle (Ghent, Belgium)
Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma: The INCA Sun randomized clinical trial R. Costello (Dublin 9, Ireland), L. Heaney (Belfast, Ireland), D. Murphy (Cork, Ireland), E. Machale (Dublin, Ireland)
Tezepelumab reduces mucus plugging in patients with uncontrolled, moderate-to-severe asthma: the phase 2 CASCADE study L. H Nordenmark (Oslo, Norway), C. Emson (Gaithersburg, MD, United States), Å. Hellqvist (Gothenburg, Sweden), J. Johnston (Cambridge, United Kingdom), H. Greberg (Gothenburg, Sweden), J. Griffiths (Gaithersburg, MD, United States), J. Newell Jr (Iowa, United States), J. Parnes (California, United States), G. Colice (Gaithersburg, MD, United States), C. Brightling (Leicester, United Kingdom)
Lockdown impact in patients with severe and very severe COPD S. Miranda Valladares (Santa Cruz de Tenerife, Spain), M. Entrambasaguas Martin (Malaga, Spain), B. Gonzalez Sanchez (Malaga, Spain), M. Perez Redondo (Malaga, Spain), F. Bernal Prados (Malaga, Spain), M. Prunera Pardell (Malaga, Spain), A. Domenech Del Rio (Malaga, Spain)
Pulmonary telerehabilitation in the COVID era - pilot program S. Alves Vaz (Vila Real, Portugal), A. Loureiro (Vila Real, Portugal), R. Rodrigues (Vila Real, Portugal), M. Padilha (Porto, Portugal)
Pulmonary rehabilitation maintenance programmes: What makes the difference? L. Silva (Porto, Portugal), T. Maricoto (Aveiro, Portugal), P. Costa (Braga, Portugal), J. Berger (Bern, Switzerland), M. Padilha (Porto, Portugal)
Pain perception in COPD patients across the COVID-19 pandemic M. Granados Santiago (Granada, Spain), J. González Dueñas (Granados, Spain), A. Calvache Mateo (Granados, Spain), Á. Benítez Feliponi (Granados, Spain), A. Heredia Ciuró (Granados, Spain), M. Valenza (Granados, Spain)
Patients’ experience of automated oxygen administration during hospitalization with acute exacerbation in COPD - a qualitative study. C. Bech (Hvidovre, Denmark), I. Poulsen (Hvidovre, Denmark), V. Nørholm (Hvidovre, Denmark), D. Bove (Hillerød, Denmark)
The impact on number of hospitalizations and lenght of hospital stay for patients with advanced COPD affiliated with a cross-sectorial lung team. B. Refsgaard Iversen (Aarhus , Denmark), L. Rodkjaer (Aarhus , Denmark), V. Bregnballe (Aarhus , Denmark), A. Løkke (Vejle, Denmark)
Impact on the quality of life of patients with COPD after three non-pharmacological interventions. S. Miranda Valladares (Santa Cruz de Tenerife, Spain), B. Gonzalez Sanchez (Malaga, Spain), M. Entrambasaguas Martin (Malaga, Spain), F. Bernal Prados (Malaga, Spain), M. Perez Redondo (Malaga, Spain), M. Prunera Pardell (Malaga, Spain), A. Domenech Del Rio (Malaga, Spain)
Comparing results of the Asthma Control Test and Severe Asthma Quality of life Questionnaire in patients with severe asthma on biologics M. Rezelj (Golnik, Slovenia), J. Tršan (Golnik, Slovenia), I. Pocvavšek (Golnik, Slovenia), T. Mocnik (Golnik, Slovenia), A. Simonic (Golnik, Slovenia), T. Morgan (Golnik, Slovenia), P. Kopac (Golnik, Slovenia), S. Škrgat (Ljubljana, Slovenia)
Recommandations pour la prise en charge de l'asthme : GINA 2021 versus SPLF 2021 / Recommendations for the management of asthma C. Raherison-Semjen (Pointe-à-Pitre (Guadeloupe), France)
IMPlementing IMProved Asthma self-management as RouTine (IMP2ART) in primary care: internal pilot for a cluster randomised controlled trial K. McClatchey (Edinburgh, United Kingdom), J. Sheringham (London, United Kingdom), A. Barat (London, United Kingdom), B. Delaney (Sheffield, United Kingdom), B. Searle (London, United Kingdom), V. Marsh (Edinburgh, United Kingdom), V. Hammersley (Edinburgh, United Kingdom), S. Taylor (London, United Kingdom), H. Pinnock (Edinburgh, United Kingdom)
Rate of admission and readmission to the emergency department (ED) associated with physician visits among patients with asthma I. Mayers (Edmonton, Canada), S. Noorduyn (Mississauga, Canada), A. Randhawa (Mississauga, Canada), M. Soliman (Mississauga, Canada), M. Talukdar (Mississauga, Canada), C. Qian (Vancouver, Canada), K. Johnston (Vancouver, Canada), P. Jayasinghe (Vancouver, Canada), M. Bhutani (Edmonton, Canada)
Delivery of supported self-management in asthma reviews: an observational study E. Kinley (Edinburgh, United Kingdom), K. Mcclatchey (Edinburgh, United Kingdom), L. Steed (London, United Kingdom), H. Pinnock (Edinburgh, United Kingdom)
Aerobic Training Reduces Chronic Airway Inflammation and Mediators of Remodelingin Asthma R. De Paula Vieira (Anápolis (GO), Brazil), R. Moraes-Ferreira (Santos, Brazil), M. A. R. Brandao-Rangel (Santos, Brazil), A. Silva-Reis (Santos, Brazil), V. H. S. Palmeira (Santos, Brazil), H. C. Aquino-Santos (Santos, Brazil), C. R. Frison (Santos, Brazil)
Discussion and Q&A
Small airways in asthma: looking deep in the lungs M. Kraft (New York, United States)
Vasculitis, EGPA and eosinophilic asthma: ties of blood A. Klion (BETHESDA, United States)
Difficult-to-manage chronic rhinosinusitis and asthma: two strangers in the same city V. Backer (Copenhagen, Denmark)
Vocal cord dysfunction and dysfunctional breathing: the underlying secrets S. Fowler (Preston (Lancashire), United Kingdom)
Late Breaking Abstract - Beyond direct costs: Individual and societal burden of asthma in young adults K. Håkansson (Copenhagen, Denmark), A. Løkke (Vejle, Denmark), R. Ibsen (Århus, Denmark), O. Hilberg (Vejle, Denmark), V. Backer (Copenhagen, Denmark), C. Ulrik (Copenhagen, Denmark)
COVID-19 real-world data (RWD) insights regarding exacerbations and serum Eosinophil levels in Asthma and Chronic Obstructive Pulmonary Disease (COPD). M. Cushion (Biggleswade, United Kingdom)
Nurses specialized through higher education in asthma, allergy and COPD. Experiences from a Swedish perspective - A winning concept for the clinic C. Stridsman (Umeå, Sweden), A. Zakrisson (Örebro, Sweden), T. Sterner (Malmö, Sweden)
Late Breaking Abstract - Mepolizumab effectiveness in severe asthma supported by federated analysis of European SHARP data J. Kroes (Leeuwarden, Netherlands), R. Alfonso-Cristancho (Brentford, United Kingdom), A. Bansal (Cambridge, United Kingdom), E. Berret (Lausanne, Switzerland), K. Bieksiene (Kaunas, Lithuania), A. Bourdin (Montpellier, France), L. Brussino (Turin, Italy), D. Canhoto (Coimbra, Portugal), C. Cardini (Milan, Italy), G. Celik (Ankara, Turkey), Z. Csoma (Budapest, Hungary), B. Dahlén (Stockholm, Sweden), E. Damadoglu (Ankara, Turkey), K. Eger (Amsterdam, Netherlands), L. Gauquelin (Paris, France), B. Gemicioglu (Istanbul, Turkey), O. Goksel (Izmir, Turkey), S. Graff (Liege, Belgium), E. Heffler (Rozzano MI, Italy), H. Hofstee (Leiden, Netherlands), P. Howarth (Brentford, United Kingdom), R. Jakes (Brentford, United Kingdom), F. Jaun (Liestal, Switzerland), V. Kalinauskaite-Zukauske (Kaunas, Lithuania), P. Kopac (Golnik, Slovenia), N. Kwon (Brentford, United Kingdom), C. Loureiro (Coimbra, Portugal), V. Lozoya García (Madrid, Spain), M. Masoli (Exeter, United Kingdom), M. Paula Rezelj (Golnik, Slovenia), L. Pérez De Llano (Lugo, Spain), S. Popovic-Grle (Zagreb, Croatia), D. Ramos-Barbon (Barcelona, Spain), A. Sà Sousa (Porto, Portugal), K. Samitas (Athens, Greece), F. Schleich (Liege, Belgium), C. Sirena (Milan, Italy), S. Skrgat (Ljubljana, Slovenia), E. Zervas (Athens, Greece), G. Zichnalis (Athens, Greece), E. Bel (Amsterdam, Netherlands), J. Sont (Leiden, Netherlands), S. Hashimoto (Amsterdam, Netherlands), A. Ten Brinke (Leeuwarden, Netherlands)
Effect of tezepelumab on a composite of severe asthma exacerbations and acute worsening events, CompEx, in the phase 3 NAVIGATOR study G. Brusselle (Ghent, Belgium), N. Martin (Leicester, United Kingdom), S. Ponnarambil (Cambridge, United Kingdom), G. Hunter (Cambridge, United Kingdom), Å. Hellqvist (Gothenburg, Sweden), M. Fagerås (Gothenburg, Sweden), C. Da Silva (Gothenburg, Sweden)
Clinical response and remission in patients with severe asthma treated with biologic treatment: Findings from the nationwide Danish Severe Asthma Registry S. Hansen (Copenhagen, Denmark), A. Von Buelow (Copenhagen, Denmark), M. Soendergaard (Copenhagen, Denmark), L. Rasmussen (Copenhagen, Denmark), C. Johnsen (Copenhagen, Denmark), T. Ingebrigtsen (Copenhagen, Denmark), K. Haakansson (Copenhagen, Denmark), K. Assing (Copenhagen, Denmark), S. Johansson (Copenhagen, Denmark), J. Schmid (Copenhagen, Denmark), A. Bjerrum (Copenhagen, Denmark), O. Hilberg (Copenhagen, Denmark), C. Ulrik (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark)
On-treatment clinical remission with tezepelumab among patients with severe, uncontrolled asthma in the phase 3 NAVIGATOR study M. Castro (Kansas City, United States), C. Ambrose (Gaithersburg, United States), G. Colice (Gaithersburg, United States), S. Roseti (Gaithersburg, United States), K. Kmita (Warsaw, Poland), B. Cook (Gaithersburg, United States), N. Martin (Leicester, United Kingdom), J. Llanos-Ackert (California, United States), A. Menzies-Gow (London, United Kingdom)
Relation between reduction in fractional exhaled nitric oxide and efficacy in asthma patients treated with dupilumab I. Pavord (Oxford (Oxfordshire), United Kingdom), Y. Deniz (Tarrytown, NY, United States), T. Casale (Tampa, FL, United States), J. Corren (Los Angeles, CA, United States), M. Fitzgerald (Vancouver, BC, Canada), N. Daizadeh (Cambridge, MA, United States), A. Jagerschmidt (Chilly-Mazarin, France), M. Dillon (Tarrytown, NY, United States), R. Gall (Tarrytown, NY, United States), N. Pandit-Abid (Bridjewater, NJ, United States), S. Siddiqui (Tarrytown, NY, United States), J. Jacob-Nara (Bridjewater, NJ, United States), P. Rowe (Bridjewater, NJ, United States), W. Busse (Madison, WI, United States)
Past smoking does not influence response to biologic therapy in patients with severe asthma M. Rahman (Southampton, United Kingdom), P. Dennison (Southampton, United Kingdom), A. Azim (Southampton, United Kingdom), A. Freeman (Southampton, United Kingdom), H. Haitchi (Southampton, United Kingdom), R. Kurukulaaratchy (Southampton, United Kingdom), H. Rupani (Southampton, United Kingdom)
Benralizumab attenuates blood and airway eosinophilia in severe asthmatics with inadequate response to anti-IL-5 neutralizing antibodies M. Mukherjee (Hamilton (ON), Canada), A. Bhalla (Hamilton (ON), Canada), C. Venegas-Garrido (Hamilton (ON), Canada), C. Huang (Hamilton (ON), Canada), K. Radford (Hamilton (ON), Canada), M. Kjarsgaard (Hamilton (ON), Canada), S. Lauks (Hamilton (ON), Canada), K. Son (Hamilton (ON), Canada), N. Lavigne (Hamilton (ON), Canada), R. Sehmi (Hamilton (ON), Canada), P. O'Byrne (Hamilton (ON), Canada), P. Nair (Hamilton (ON), Canada)
Dupilumab improved lung function and reduces exacerbations in patients with 1, 2, or 3 prior exacerbations: TRAVERSE J. Corren (Los Angeles, CA, United States), M. Castro (Kansas City, KS, United States), J. Maspero (Buenos Aires, Argentina), M. Humbert (Le Kremlin-Bicêtre, France), D. Halpin (Exeter, United Kingdom), A. Altincatal (Cambridge, MA, United States), N. Pandit-Abid (Bridgewater, NJ, United States), X. Soler (Tarrytown, NY, United States), S. Siddiqui (Tarrytown, NY, United States), J. Jacob-Nara (Bridgewater, NJ, United States), Y. Deniz (Tarrytown, NY, United States), P. Rowe (Bridgewater, NJ, United States), J. Maspero (Ciudad Autónoma Buenos Aires, Argentina)